Further tests are needed but a trial showed that, when compared against placebo treatment, those given the drug had a 79% lower risk of developing severe disease.
L’expertise universitaire, l’exigence journalistique
Articles sur Clinical trials
Affichage de 21 à 40 de 149 articles
The race is on to develop a vaccine for the COVID-19 coronavirus. Australian researchers are leading several major clinical trials that might help bring an end to the deadly disease.
Investments are starting to help grow the African continent's science preparedness.
Amyotrophic lateral sclerosis, Lou Gehrig's disease, is a crippling, progressive neurodegenerative disease for which there is no cure. Now it seems that a diabetes drug may help some cases.
Immunosenescence — the decline of immune system function with age — means that vaccines are not as effective in older adults, the demographic most susceptible to many diseases, including COVID-19.
The experimental vaccine stimulates the creation of antibodies. Now we need to show that these effectively protect us from the coronavirus.
Pluralism — the active process of inclusion — could reduce disparities in some of the most pressing health issues of our time.
A vaccine that's 70% effective might not be good enough if too few people are willing to be vaccinated, new research shows.
Severe scrutiny of two major papers, including one about the effectiveness of hydroxychloroquine, is part of science's normal process of self-correction.
It usually takes 10 years for a new vaccine to complete clinical trials, but we've been promised a COVID-19 vaccine in 12 to 18 months. Even if such fast-tracked development is possible, is it wise?
The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?
There is a growing call for so-called challenge trials to speed up vaccine development.
Early clinical trials into ginseng, rhubarb and rice paved the way for testing coronavirus treatments today.
Drugs and vaccines to fight the coronavirus are already in clinical trials. It is important to understand the difference between each step in this process as efforts to fight COVID-19 continue.
Our expert assessed all the controlled studies so far on hydroxychloroquine. His findings may surprise you.
Africa needs to be better prepared to deal with future pandemics. That should start with a re-assessment of how countries invest in – and support – local research.
The only way to know if a medical treatment actually works is with a randomized-controlled trial.
A century old therapy is being tested on patients with COVID-19.
A simple head-to-head trial would resolve this conflict once and for all.
Army physicians are turning to drugs approved for other conditions or newly developed treatments such as the antiviral Remdesivir to treat infected personnel.
Les contributeurs les plus fréquents
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Director of the Oxford Empathy Programme, University of Oxford
-
Epidemiologist, Cochrane
-
Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto
-
Professor of Immunology, RMIT University
-
Professor of Medicine, Monash University
-
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney
-
Senior Research Fellow, Bioethics, University of Sydney
-
Ian Haines est un·e ami·e de La Conversation
Adjunct Clinical Associate Professor, AMREP Department of Medicine, Alfred Hospital, Melbourne & Senior Medical Oncologist and Palliative Care Physician, Melbourne Oncology Group, Cabrini Haematology and Oncology Centre, Wattletree Road, Malvern, Monash University
-
Head, Cancer Research Program, Monash University
-
Senior Lecturer in Medical Ethics and Law, St George's, University of London
-
Researcher, L’Université d’Ottawa/University of Ottawa
-
Professsor of Public Health; Co-Director Consortium for Advanced Research Training in Africa; Panel Member, Private Healthcare Market Inquiry, University of the Witwatersrand
-
Assistant Professor of Law, Saint Louis University
-
Associate professor, UNSW
